Accelerating Vaccine Development & Manufacturing

Our recent experience with Covid-19 has shown us that in times of a global crisis the world looks to the Life Science industry to perform at its best, but it is not enough to just develop an effective vaccine, Life Sciences companies also need to be able to manufacture it and distribute it - at pandemic speed.

To be successful, pharmaceuticals companies and CMOs have to create new partnerships to address the high vaccine demand, industrialize new vaccine technologies and ensure they are first to market. Modern digital collaboration platforms are needed now more than ever to seamlessly and securely exchange data with partners, from; tech transfer to plant design, batch release to predictive analytics and supply-chain to supply network.

The Dassault Systèmes 3DEXPERIENCE® platform provides a unique environment for biopharma manufacturers - transforming vaccine development and manufacturing operations by providing visibility across the enterprise, seamlessly and securely allowing data exchange with CDMO partners, from tech transfer to plant design, allowing data-driven decision making and connecting the dots from vaccine design, development & clinical trials, manufacturing through to commercialization. The 3DEXPERIENCE platform infuses virtualization and simulation into manufacturing planning and operations helping to ensure high quality therapies are produced as designed and as registered quickly and cost-effectively.